Cosmos Health (NASDAQ:COSM) Trading 5.7% Higher – Still a Buy?

Shares of Cosmos Health Inc. (NASDAQ:COSM) traded up 5.7% during trading on Monday . The company traded as high as $0.8198 and last traded at $0.7294. 272,319 shares changed hands during mid-day trading, a decline of 58% from the average session volume of 650,314 shares. The stock had previously closed at $0.69.

Analyst Ratings Changes

COSM has been the subject of a number of research reports. Wall Street Zen upgraded Cosmos Health to a “hold” rating in a report on Saturday, September 20th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Cosmos Health in a report on Wednesday, October 8th. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock has an average rating of “Sell”.

Cosmos Health Stock Performance

The business has a fifty day simple moving average of $0.94 and a two-hundred day simple moving average of $0.70. The company has a market cap of $22.62 million, a PE ratio of -0.71 and a beta of 5.32. The company has a debt-to-equity ratio of 0.08, a current ratio of 0.98 and a quick ratio of 0.82.

Cosmos Health (NASDAQ:COSM) last issued its quarterly earnings data on Tuesday, October 10th. The company reported $0.27 earnings per share for the quarter. Cosmos Health had a negative return on equity of 18.32% and a negative net margin of 27.90%.The firm had revenue of $12.35 million during the quarter. Research analysts anticipate that Cosmos Health Inc. will post -0.78 earnings per share for the current year.

Institutional Inflows and Outflows

An institutional investor recently raised its position in Cosmos Health stock. Armistice Capital LLC increased its position in shares of Cosmos Health Inc. (NASDAQ:COSM) by 156.1% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,917,710 shares of the company’s stock after acquiring an additional 1,168,884 shares during the quarter. Armistice Capital LLC owned about 7.03% of Cosmos Health worth $836,000 as of its most recent SEC filing. 12.61% of the stock is currently owned by hedge funds and other institutional investors.

Cosmos Health Company Profile

Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names.